Cargando…
Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB(-CTE) Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study
BACKGROUND: Visceral leishmaniasis is the most severe form of leishmaniasis caused by Leishmania (L.) donovani complex. Drug-resistant strains have been developed as a consequence of the current chemotherapeutic interventions, which has increased the need for advanced preventive and therapeutic stra...
Autores principales: | TASLIMI, Yasaman, ZAHEDIFARD, Farnaz, TAHERI, Tahereh, DOROUD, Delaram, LATIF DIZAJI, Sakineh, SALJOUGHIAN, Noushin, RAFATI, Sima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548471/ https://www.ncbi.nlm.nih.gov/pubmed/33082803 http://dx.doi.org/10.18502/ijpa.v15i3.4203 |
Ejemplares similares
-
C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice
por: Doroud, Delaram, et al.
Publicado: (2011) -
Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2013) -
Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011) -
Novel Selective and Low-Toxic Inhibitor of LmCPB2.8ΔCTE (CPB) One Important Cysteine Protease for Leishmania Virulence
por: Moreira, Vitor Partite, et al.
Publicado: (2022) -
Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy
por: Taslimi, Yasaman, et al.
Publicado: (2016)